U.S. Agent, Initial Importer, and Importer of Record: Three Different Roles

The FDA U.S. Agent, Initial Importer, and Importer of Record each serve a distinct purpose in a U.S. market entry. Although the titles sound similar, they belong to different regulatory systems and are not interchangeable.

Each Role Serves a Different Regulatory Purpose

A foreign medical-device manufacturer entering the United States may encounter three roles that sound similar but belong to different regulatory systems. Assigning one role does not automatically satisfy the responsibilities of the others.

U.S. Agent — FDA Communication Role

A foreign establishment registered with the U.S. Food and Drug Administration must designate a U.S. Agent. The agent assists with FDA communications, responds to questions concerning the foreign establishment and its devices, and helps arrange FDA inspections.

The role does not, by itself, make the agent a distributor, customs importer, complaint handler, recall coordinator, or financially responsible party. Those responsibilities require separate appointment, operational capability, and, where applicable, additional registrations.

Initial Importer — FDA Post-Market Role

The Initial Importer is the U.S. establishment that furthers the marketing of a device from a foreign manufacturer toward final delivery or sale to the ultimate user without repackaging or changing the device's labeling.

Initial Importers must register with FDA and assume defined post-market responsibilities, including Medical Device Reporting, complaint handling, and reporting corrections and removals.

A warehouse, customs broker, customer, or U.S. Agent does not automatically become the Initial Importer simply because it handles the shipment or appears on import documentation.

Importer of Record — Customs Entry Role

The Importer of Record is the party responsible to U.S. Customs and Border Protection for the customs entry. This role includes exercising reasonable care over tariff classification, customs value, country of origin, entry documentation, duties, fees, and other admissibility requirements.

Although a customs broker may prepare and transmit the customs entry, the broker's involvement generally does not transfer the Importer of Record's underlying legal responsibility.

Why a Launch May Require One, Two, or All Three Roles

Most commercial import structures involve all three functions. What varies is whether the manufacturer already has qualified organizations performing some of the roles or must appoint additional service providers.

One manufacturer may already have a U.S.-based employee serving as its U.S. Agent while using several distributors, creating a need for a dedicated Initial Importer. Another manufacturer may retain its own U.S. Agent and Initial Importer while allowing a distributor, customer, or specialized import service to serve as the Importer of Record.

Companies selling directly to hospitals, dealers, or patients may require a coordinated provider capable of performing all three functions.

Design the Structure Before Launch

The correct structure depends on ownership of the goods, contractual sales flow, delivery terms, customs-entry arrangements, complaint routing, and who continues marketing the device after importation.

The same organization can perform multiple roles, but each responsibility should be assigned deliberately and supported by the appropriate agreements, registrations, quality systems, records, insurance, and operational processes.

MDD Options can provide an integrated U.S. Agent, Initial Importer, and Importer of Record structure within its Hybrid distribution model, including import coordination, compliant device storage, order fulfillment, complaint intake, and post-market routing. Where another distributor or customer already performs part of the chain, MDD Options can assess the existing allocation and fill only the operational or regulatory gaps required for a successful U.S. launch.